Tops & Flops Stocks
Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
---|---|---|---|---|---|---|---|
Viking Therapeutics Inc | -7.250% | 18.991% | 14.280% | 331.250% | 223.592% | 1085.170% | 711.299% |
Geron Corp. | 3.800% | 1.025% | 9.684% | 50.625% | 120.427% | 317.517% | 305.345% |
Savara Inc. | -2.400% | 2.970% | 9.474% | 35.065% | -3.704% | 285.185% | 79.079% |
Eli Lilly Corp. | -2.090% | -6.196% | -11.773% | 79.509% | 41.364% | 261.803% | 664.911% |
Ardelyx Inc. | 0.160% | -1.683% | -25.521% | 46.496% | -11.038% | 257.083% | - |
Madrigal Pharmaceuticals inc. | 0.630% | -3.867% | -2.947% | 36.381% | 19.962% | 247.397% | 222.975% |
Catalyst Pharmaceutical Partners Inc | 0.620% | 3.457% | 15.018% | 27.294% | 3.990% | 228.723% | 271.110% |
Insmed Inc. | 0.740% | -1.449% | 8.800% | 259.788% | 137.762% | 223.810% | 228.423% |
Voyager Therapeutics Inc | 0.240% | 4.591% | 15.321% | 2.182% | 6.038% | 214.552% | -58.185% |
Vertex Pharmaceuticals Inc. | 0.670% | 1.054% | 5.141% | 43.260% | 23.813% | 173.086% | 208.494% |
Intra-Cellular Therapies Inc. | -1.380% | 2.837% | 13.281% | 31.341% | 11.196% | 146.515% | 894.786% |
Medpace Holdings Inc | -1.740% | -12.425% | -8.507% | 51.922% | 25.160% | 137.635% | 479.216% |
Sarepta Therapeutics | -1.560% | 0.409% | -8.506% | 37.112% | 52.577% | 132.678% | 1.565% |
Cytokinetics Inc. | -2.730% | 3.774% | 13.636% | 85.811% | -28.105% | 123.577% | 400.455% |
Ani Pharmaceuticals Inc. | -0.870% | - | -3.390% | 19.247% | 14.458% | 105.036% | -25.432% |
Regeneron Pharmaceuticals Inc. | -0.380% | 1.283% | 1.242% | 47.051% | 24.740% | 102.979% | 262.338% |
United Therapeutics | 0.260% | 1.374% | 4.205% | 39.236% | 56.267% | 99.871% | 340.057% |
Corcept Therapeutics Inc. | 4.710% | 10.334% | 12.579% | 46.696% | 12.467% | 93.908% | 238.212% |
Axsome Therapeutics Inc | 0.770% | -1.645% | 3.460% | 8.849% | 8.152% | 83.090% | 226.845% |
Merck & Co. Inc. | -9.640% | 2.249% | 1.199% | 22.487% | 20.000% | 82.661% | 59.730% |